How AI Is Reducing The Costly Toll Of Cancer Drug Development And Disrupting The BioPharma Space
November 24, 2021 at 01:01 AM EST
Bio-pharmaceutical investors know full well the drug discovery and development can be a long and uncertain process. Nowhere is that more true than in cancer drugs. This review looks at the history and trends in cancer drug approval.
